News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Glenn Gregory M
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/14/2023 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Bought 3,000 shares
@ $7.4845, valued at
$22.5k
Bought 2,000 shares
@ $7.044, valued at
$14.1k
Bought 1,000 shares
@ $6.5, valued at
$6.5k
Exercised 6,298 shares
@ $6.52, valued at
$41.1k
Paid exercise price by delivering 2,432 shares
@ $6.52, valued at
$15.9k
Exercised 6,298 restricted stock units
@ $0 |
|
12/16/2022 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Paid exercise price by delivering 1,033 shares
@ $17.23, valued at
$17.8k
Exercised 3,100 restricted stock units
@ $0 |
|
03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/30/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 185 shares
@ $215.0036, valued at
$39.8k
Sold 260 shares
@ $216.1873, valued at
$56.2k
Sold 331 shares
@ $217.3602, valued at
$71.9k
Sold 626 shares
@ $218.2544, valued at
$136.6k
Sold 412 shares
@ $219.2546, valued at
$90.3k
Sold 155 shares
@ $220.2217, valued at
$34.1k
Sold 114 shares
@ $221.2429, valued at
$25.2k
Disposed/sold 38 shares
@ $217.97, valued at
$8.3k
Paid exercise price by delivering 647 shares
@ $217.97, valued at
$141k
Exercised 2,083 options to buy
@ $5.95, valued at
$12.4k
Exercised 1,377 rights
@ $5.95, valued at
$8.2k
|
|
11/24/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 800 shares
@ $196.4288, valued at
$157.1k
Sold 1,400 shares
@ $197.4421, valued at
$276.4k
Sold 1,271 shares
@ $198.4676, valued at
$252.3k
Sold 1,387 shares
@ $199.5096, valued at
$276.7k
Sold 1,600 shares
@ $200.5544, valued at
$320.9k
Sold 722 shares
@ $201.4786, valued at
$145.5k
Sold 870 shares
@ $202.646, valued at
$176.3k
Sold 200 shares
@ $203.615, valued at
$40.7k
Exercised 8,250 options to buy
@ $19.08, valued at
$157.4k
|
|
11/17/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 1,183 shares
@ $172.0167, valued at
$203.5k
Sold 500 shares
@ $166.892, valued at
$83.4k
Sold 1,472 shares
@ $167.9519, valued at
$247.2k
Sold 1,326 shares
@ $168.906, valued at
$224k
Sold 4,352 shares
@ $170.2613, valued at
$741k
Sold 600 shares
@ $170.9367, valued at
$102.6k
Exercised 521 options to buy
@ $27.6, valued at
$14.4k
Exercised 662 options to buy
@ $46, valued at
$30.5k
Exercised 8,250 options to buy
@ $19.08, valued at
$157.4k
|
|
11/12/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 400 shares
@ $164.2325, valued at
$65.7k
Sold 1,400 shares
@ $165.7236, valued at
$232k
Sold 1,800 shares
@ $166.5461, valued at
$299.8k
Sold 2,000 shares
@ $167.7585, valued at
$335.5k
Sold 672 shares
@ $168.4589, valued at
$113.2k
Sold 1,478 shares
@ $169.5416, valued at
$250.6k
Sold 400 shares
@ $170.5475, valued at
$68.2k
Sold 100 shares
@ $171.48, valued at
$17.1k
Exercised 8,250 options to buy
@ $19.08, valued at
$157.4k
|
|
11/04/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 600 shares
@ $177.115, valued at
$106.3k
Sold 1,200 shares
@ $178.1242, valued at
$213.7k
Sold 900 shares
@ $179.0889, valued at
$161.2k
Sold 600 shares
@ $180.4133, valued at
$108.2k
Sold 670 shares
@ $181.5482, valued at
$121.6k
Sold 600 shares
@ $182.5783, valued at
$109.5k
Sold 800 shares
@ $183.575, valued at
$146.9k
Sold 302 shares
@ $184.8187, valued at
$55.8k
Sold 500 shares
@ $186.094, valued at
$93k
Sold 300 shares
@ $187.2567, valued at
$56.2k
Sold 300 shares
@ $188.33, valued at
$56.5k
|
|
11/02/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 39 shares
@ $145.4077, valued at
$5.7k
Sold 108 shares
@ $146.5061, valued at
$15.8k
Sold 138 shares
@ $148.0814, valued at
$20.4k
Sold 353 shares
@ $148.9851, valued at
$52.6k
Sold 16 shares
@ $149.64, valued at
$2.4k
Sold 26 shares
@ $152.1646, valued at
$4k
|
|
10/28/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 1,500 shares
@ $130.9347, valued at
$196.4k
Sold 3,000 shares
@ $131.91, valued at
$395.7k
Sold 3,134 shares
@ $133.0173, valued at
$416.9k
Sold 1,700 shares
@ $133.8229, valued at
$227.5k
Sold 1,000 shares
@ $135.16, valued at
$135.2k
Disposed/sold 61 shares
@ $134.99, valued at
$8.2k
Paid exercise price by delivering 637 shares
@ $134.99, valued at
$86k
Exercised 2,084 options to buy
@ $5.95, valued at
$12.4k
Exercised 8,250 options to buy
@ $19.08, valued at
$157.4k
Exercised 1,378 rights
@ $5.95, valued at
$8.2k
|
|
10/21/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 1,591 shares
@ $161.0007, valued at
$256.2k
Sold 893 shares
@ $162.0489, valued at
$144.7k
Sold 400 shares
@ $163.0075, valued at
$65.2k
Sold 1,400 shares
@ $164.8475, valued at
$230.8k
Sold 1,000 shares
@ $165.984, valued at
$166k
Sold 1,366 shares
@ $167.0825, valued at
$228.2k
Sold 800 shares
@ $168.4929, valued at
$134.8k
Sold 300 shares
@ $169.8467, valued at
$51k
Sold 400 shares
@ $171.015, valued at
$68.4k
Sold 100 shares
@ $172.03, valued at
$17.2k
Exercised 8,250 options to buy
@ $19.08, valued at
$157.4k
|
|
10/19/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 1,183 shares
@ $170, valued at
$201.1k
Exercised 521 options to buy
@ $27.6, valued at
$14.4k
Exercised 662 options to buy
@ $46, valued at
$30.5k
|
|
10/14/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 1,000 shares
@ $161.582, valued at
$161.6k
Sold 2,900 shares
@ $162.4493, valued at
$471.1k
Sold 2,858 shares
@ $163.3817, valued at
$466.9k
Sold 800 shares
@ $164.5013, valued at
$131.6k
Sold 392 shares
@ $165.6991, valued at
$65k
Sold 300 shares
@ $166.7767, valued at
$50k
Exercised 8,250 options to buy
@ $19.08, valued at
$157.4k
|
|
10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/22/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 119 shares
@ $200.6071, valued at
$23.9k
Sold 199 shares
@ $202.756, valued at
$40.3k
Sold 61 shares
@ $203.3916, valued at
$12.4k
Sold 119 shares
@ $204.7071, valued at
$24.4k
Sold 181 shares
@ $205.6627, valued at
$37.2k
Sold 135 shares
@ $206.8173, valued at
$27.9k
Sold 126 shares
@ $207.63, valued at
$26.2k
Sold 63 shares
@ $211.93, valued at
$13.4k
Sold 141 shares
@ $213.5455, valued at
$30.1k
Sold 126 shares
@ $214.755, valued at
$27.1k
Sold 56 shares
@ $217.44, valued at
$12.2k
|
|
07/19/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 730 shares
@ $177.6225, valued at
$129.7k
Sold 2,318 shares
@ $178.1931, valued at
$413.1k
Sold 796 shares
@ $179.2935, valued at
$142.7k
Sold 550 shares
@ $180.5727, valued at
$99.3k
Sold 560 shares
@ $181.4469, valued at
$101.6k
Sold 300 shares
@ $182.3766, valued at
$54.7k
Sold 399 shares
@ $183.8114, valued at
$73.3k
Sold 1 shares
@ $184.2704, valued at
$184.3 Disposed/sold 161 shares
@ $179.14, valued at
$28.8k
Paid exercise price by delivering 2,253 shares
@ $179.14, valued at
$403.6k
Exercised 550 options to buy
@ $27, valued at
$14.9k
|
|
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2021 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Sold 901 shares
@ $196.8799, valued at
$177.4k
Sold 1,939 shares
@ $197.8661, valued at
$383.7k
Sold 1,490 shares
@ $199.0712, valued at
$296.6k
Sold 1,282 shares
@ $200.1449, valued at
$256.6k
Sold 100 shares
@ $201.47, valued at
$20.1k
Exercised 4,819 shares
@ $217.46, valued at
$1M
Disposed/sold 132 shares
@ $217.46, valued at
$28.7k
Paid exercise price by delivering 2,264 shares
@ $217.46, valued at
$492.3k
Sold 5 shares
@ $210.85, valued at
$1.1k
Sold 57 shares
@ $211.9572, valued at
$12.1k
Sold 57 shares
@ $213.0125, valued at
$12.1k
|
|
02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2020 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC
Txns:
| Granted 18,700 options to buy
@ $129.7, valued at
$2.4M
Granted 9,300 restricted stock units
@ $0 |
|
09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|